Garnet Biotherapeutics, Inc.

United States of America

Create a watch for Garnet Biotherapeutics, Inc.
Total IP 10
Total IP Rank # 156,638
IP Activity Score 0/5.0    0
IP Activity Rank # 1,700,513

Patents

Trademarks

4 0
1 0
5 0
0
 
Last Patent 2022 - Methods of ganglioside production
First Patent 2001 - novel synthetic gangliosides

Latest Inventions, Goods, Services

2021 Invention Methods of ganglioside production. The invention provides methods for production of gangliosides...
2014 Invention Ganglioside compositions. The invention provides novel gangliosides and mixtures of novel gangli...
Invention Thermoresponsive polymer applications for adherent cell culture and recovery. The invention provi...
Invention Ganglioside compositions. The invention provides novel gangliosides and mixtures of novel ganglio...
2013 Invention Treatment of diseases and disorders using self-renewing colony forming cells cultured and expande...
Invention Compositions and methods of using living and non-living bioactive devices with components derived...
Invention Methods of ganglioside production. The invention provides methods for production of gangliosides,...
Invention Cell populations which co-express cd49c and cd90. Substantially homogenous cells populations whi...
2008 Invention Administering a biological composition or compositions isolated from self-renewing colony forming...
2007 Invention Cell populations which co-express cd49c and cd90. Substantially homogenous cells populations whic...
2001 Invention novel synthetic gangliosides. Disclosed is a synthetic ganglioside comprising a deamino-(2-O-sub...